Raphael Pharmaceutical (RAPH) Selling, General & Administrative (2020 - 2026)
Raphael Pharmaceutical (RAPH) reported Selling, General & Administrative of $159,000 for Q2 2026, down 8.6% from $174,000 a year earlier.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Raphael Pharmaceutical's Selling, General & Administrative came in at $673,000, down 8.9% year-over-year; for FY2025, it came in at $614,000, down 16.2% from FY2024.
- Selling, General & Administrative has declined for three consecutive years, though with a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $733,000 in FY2024 (-3.9%), $763,000 in FY2023 (-64.3%), $2.14 million in FY2022 (+150.8%) and $853,000 in FY2021 (+248.2%).
- The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q3 2024.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2022 (growth of 325.7%); the low point was Q3 2023 (a decline of 80.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.18 Mn | - | 159,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 159,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 157,000.00 |
| Jun 30, 2024 | 225,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 274,000.00 |
| Sep 30, 2023 | 219,000.00 |
| Jun 30, 2023 | 126,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 428,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Dec 31, 2021 | 350,000.00 |
| Sep 30, 2021 | 257,000.00 |
| Jun 30, 2021 | 163,000.00 |
| Mar 31, 2021 | 83,000.00 |
| Dec 31, 2020 | 7,000.00 |
API Access
Raphael Pharmaceutical Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RAPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RAPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RAPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();